Core Viewpoint - A class action lawsuit has been filed against Klarna Group plc on behalf of investors who purchased its securities during the September 2025 IPO, alleging misleading statements and failure to disclose material adverse facts about the company's financial health and risk profile [1][4]. Group 1: IPO Details - Klarna conducted its IPO on September 10, 2025, selling 34.3 million shares at a price of $40 per share [3]. - Following the IPO, Klarna's stock price experienced a significant decline after the release of its third quarter 2025 financial results, which revealed a 39% increase in provision for credit losses [3]. Group 2: Financial Performance - The increase in credit loss provisions was attributed to changes in market and product mix, particularly an increased share of the U.S. market in its Gross Merchandise Volume (GMV) [3]. - On November 18, 2025, the stock price fell by $3.25, or 9.3%, closing at $31.63 per share, indicating investor injury due to the disclosed financial issues [3]. Group 3: Lawsuit Allegations - The lawsuit alleges that Klarna's management made materially false and misleading statements regarding the company's business and operations [4]. - Specifically, it is claimed that the risk of increased loss reserves was materially understated, which management either knew or should have known, given the risk profile of consumers using Klarna's buy now, pay later (BNPL) loans [4]. - The positive statements made by the defendants about the company's prospects were deemed materially misleading and lacked a reasonable basis [4].

Core Viewpoint - Firefly Aerospace Inc. is facing a class action lawsuit due to alleged violations of securities laws related to its initial public offering (IPO) and subsequent financial disclosures, which reportedly misrepresented the company's growth prospects and operational readiness [1][3]. Company Overview - Firefly Aerospace operates in the space and defense technology sector, providing mission solutions for national security, government, and commercial customers [2]. IPO Details - The company conducted its IPO on August 7, 2025, issuing approximately 19.3 million shares at an offering price of $45.00 per share [2]. Allegations of Misrepresentation - The lawsuit claims that Firefly Aerospace overstated demand and growth prospects for its Spacecraft Solutions offerings and the operational readiness of its Alpha rocket program, which could have a material negative impact once revealed [3]. Financial Performance - In its first earnings report as a public company on September 22, 2025, Firefly Aerospace reported a loss of $80.3 million for Q2 2025, compared to a loss of $58.7 million in Q2 2024. Revenue was reported at $15.55 million, below analyst estimates of $17.25 million, and down 26.2% year-over-year [4]. - The Spacecraft Solutions business segment reported revenue of only $9.2 million, representing a 49% year-over-year decrease [4]. Stock Price Impact - Following the earnings report, Firefly Aerospace's stock price fell more than 15%. Additionally, on September 29, 2025, the company disclosed an issue with its Alpha Flight 7 rocket, leading to a further decline of over 20% in share price [4][5].

LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Above Food Ingredients, Inc., (“Above Food" or the "Company") (NASDAQ: ABVE) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.  Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/above-food-ingredients-in ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Charming Medical Ltd. (NASDAQ: MCTA) (“Charming”) that a federal securities class action has been filed on behalf of investors who purchased Integer between October 21, 2025 and November 12, 2025, inclusive (the “Class Period”). Investors have until February 17, 2026 to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The filed complaint ...

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into Ramaco Resources, Inc. for possible securities fraud, potentially leading to a class action lawsuit on behalf of investors [1]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm is encouraging investors to contact them to discuss their legal rights and options for pursuing claims to recover losses [2]. - The investigation follows a report by Wolfpack Research, which alleged that Ramaco's Brook Mine project was a "hoax" and that the company manipulated data to misrepresent profitability [3]. Group 2: Stock Price Impact - Following the allegations from Wolfpack Research, Ramaco's stock price dropped by $3.81, or 9.5%, closing at $36.01 per share on October 23, 2025, resulting in financial harm to investors [3]. Group 3: Firm's Background - The Portnoy Law Firm has a history of representing investors in claims related to corporate wrongdoing, having recovered over $5.5 billion for aggrieved investors [4].

Core Viewpoint - A class action securities lawsuit has been filed against DeFi Technologies, alleging securities fraud that affected investors between May 12, 2025, and November 14, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that DeFi Technologies faced delays in executing its DeFi arbitrage strategy, which was a key revenue driver for the company [2] - It is alleged that DeFi Technologies understated the competition from other digital asset treasury companies, impacting its ability to execute its DeFi arbitrage strategy [2] - The company is said to be unlikely to meet its previously issued revenue guidance for the fiscal year 2025 due to these issues [2] - Defendants allegedly downplayed the true scope and severity of the negative impacts on DeFi Technologies' business and financial results [2] - Public statements made by the defendants were claimed to be materially false and misleading [2] Group 2: Legal Process and Participation - Investors who suffered losses in DeFi Technologies during the relevant time frame have until January 30, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4]

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avantor, Inc. investors who were adversely affected by alleged securities fraud between March 5, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/avantor-inc-lawsuit-s ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/p ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

San Diego, California--(Newsfile Corp. - December 23, 2025) - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors.If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and ...